Shanghai Shyndec Pharmaceutical Co. Ltd. A | Ownership
Companies that own Shanghai Shyndec Pharmaceutical Co. Ltd. A
Harvest Fund Management Co., Ltd.
15,926,404
2.77%
15,926,404
0.16%
06/30/2017
Rongtong Fund Management Co., Ltd.
12,532,293
2.18%
-786,447
0.68%
12/31/2017
Citic Securities Co., Ltd. (Invt Port)
9,792,328
1.7%
-14,332,420
0.91%
06/30/2017
HSBC Jintrust Management Co., Ltd.
8,196,257
1.42%
8,196,257
0.59%
12/31/2017
Zhong Ou Asset Management Co., Ltd
5,887,270
1.02%
5,887,270
0.16%
12/31/2017
Fullgoal Fund Management Co., Ltd.
5,080,314
0.88%
4,775,134
0.07%
12/31/2017
Chang Xin Asset Management Co., Ltd.
1,679,881
0.28%
1,645,481
0.1%
12/31/2017
Bosera Asset Management Co., Ltd.
1,000,000
0.17%
-1,000,120
0.01%
12/31/2017
Guotai Asset Management Co., Ltd.
994,075
0.17%
994,075
0.02%
12/31/2017
Beixin Ruifeng Fund Management Co. Ltd.
936,000
0.16%
-136,700
0.03%
12/31/2017
| Address |
1320 Beijing West Road
Shanghai Shanghai 200040
China
|
|
Employees
|
- |
| Website |
http://www.shyndec.com |
| Updated |
07/08/2019 |
| Shanghai Shyndec Pharmaceutical Co., Ltd. principally engages in the research, development, manufacturing, and sale of pharmaceutical products. Its product range covers anti-infective drugs, cardiovascular and cerebrovascular drugs, anti-tumour drugs, anaesthetic psychotropic drugs, as well as metabolic and endocrine drugs. The company was founded in 1996 and is headquartered in Shanghai, China. |
